Delivery Order SPE2DB20D7066-SPE2DB25FC3PC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $98,923.44 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This competitively awarded, firm fixed-price contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services to the federal government under its existing contract vehicle...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 26, 2025, valued at $33,524.40 for the supply of Xeomin 100 unit vials to support the Defense Department's Medical Supply Chain. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, and performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,174.80 on August 15, 2025, for the supply of Xeomin 100 Unit Vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 8, 2025, and is being funded through the Defense Medical Supply Chain, which supports pharmaceutical procurement for military and veteran healthcare systems. The award represents a child delivery order under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,644.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xeomin 200 unit vials. The contract utilizes firm fixed price terms with an ultimate completion date of June 24, 2025, and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,699.64 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, utilizing firm fixed-price pricing, covers the supply of Xeomin 100 unit vials and is scheduled for completion by August 27, 2025. The award was made through open competition with no set-aside designation, with performance taking place at the vendor's corporate office...
- AmerisourceBergen Drug Corp was awarded a $5,587.40 delivery order by the Defense Logistics Agency (DLA) on October 23, 2025, for the supply of 100-unit vials of Xeomin. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Xeomin 200 unit vials, with a ceiling value of $13,409.76 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 20, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3PCDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,057.32 by the Defense Logistics Agency on June 2, 2025, for the supply of Xeomin 100 unit vials, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive federal contract portfolio. The Xeomin supply under this delivery order supports the Defense Logistics Agency's medical supply chain requirements for military and veteran healthcare systems. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its established position as a prime vendor under the DLA's pharmaceutical support program, reflects its strategic role in sustaining defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 6/2/25 |